Phase 1: Research Consulting & Strategic Blueprint
Prior-Art Patent Audit, Whitespace Analysis & Target Product Profile (TPP)
The foundational stage for pharmaceutical, biotech, veterinary, and medical cannabis formulation projects. Innoeco pharmaceutical scientists deploy LegacyMap to forensicly analyze prior-art patents and scientific literature, utilize MarketView for therapeutic whitespace mapping, and construct a detailed Target Product Profile (TPP) and formulation risk blueprint to de-risk investment before physical compounding.
• Formal Target Product Profile (TPP) & Risk Blueprint
• LegacyMap Prior-Art Patent, Literature & Synthetic Pathway Audit
• MarketView Therapeutic Whitespace & Clinical Indication Matrix
• Formulation Feasibility & Go/No-Go Stage-Gate Decision Report
Custom Scoping (Indexed to Baseline: R 13,600+)